Shire-NPS Pharmaceuticals, Inc.
Shire-NPS Pharmaceuticals, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 1986, the company has established itself as a leader in developing innovative therapies for rare diseases, particularly in the fields of gastrointestinal and endocrine disorders.
With a strong focus on patient-centric solutions, Shire-NPS offers a range of unique products, including treatments for conditions such as short bowel syndrome and hypoparathyroidism. The company’s commitment to research and development has led to significant milestones, including the successful launch of several groundbreaking therapies.
Recognised for its expertise in rare disease management, Shire-NPS Pharmaceuticals continues to strengthen its market position, making a meaningful impact on the lives of patients worldwide.
+38 vs industry average
Shire-NPS Pharmaceuticals, Inc.’s score of 76 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Shire-NPS Pharmaceuticals, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Shire-NPS Pharmaceuticals, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Shire-NPS Pharmaceuticals, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Shire-NPS Pharmaceuticals, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Takeda Pharmaceutical Company Limited
Carbon Disclosure Project
Inherited from Takeda Pharmaceutical Company Limited
The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Takeda Pharmaceutical Company Limited
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project